Advertisement

Topics

Artelo, Syngene Enter Partnership

04:32 EDT 14 Jun 2018 | Contract Pharma

For the drug discovery and clinical development of ART27.13, Artelo's Phase 2 ready, high-potency dual cannabinoid agonist

Original Article: Artelo, Syngene Enter Partnership

NEXT ARTICLE

More From BioPortfolio on "Artelo, Syngene Enter Partnership"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...